A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

CompletedOBSERVATIONAL
Enrollment

2,300

Participants

Timeline

Start Date

March 3, 2014

Primary Completion Date

October 17, 2017

Study Completion Date

October 17, 2017

Conditions
Liver TransplantKidney Transplant
Interventions
DRUG

Tacrolimus

oral

Trial Locations (145)

4

Site IE35301, Dublin

1070

Site BE32002, Brussels

1082

Site HU36001, Budapest

1090

Site AT43002, Vienna

Site BE32007, Brussels

3000

Site BE32003, Leuven

Site BE32005, Leuven

3010

Site CH41002, Bern

4000

Site BE32008, Liège

Site BE32009, Liège

4010

Site AT43003, Linz

4012

Site HU36003, Debrecen

6002

Site FR33015, Nice

6020

Site AT43001, Innsbruck

6120

Site DE49014, Halle

6720

Site HU36002, Szeged

8916

Site ES34012, Badalona-Barcelona

9000

Site BE32001, Ghent

13353

Site DE49004, Berlin

13385

Site FR33011, Marseille

14004

Site ES34010, Córdoba

14186

Site SE46002, Stockholm

15006

Site ES34005, A Coruña

16132

Site IT39006, Genova

18057

Site DE49017, Rostock

20132

Site IT39012, Milan

20162

Site IT39009, Milan

21079

Site FR33032, Dijon

22328

Site RO40001, Bucharest

Site RO40003, Bucharest

24105

Site DE49002, Kiel

24122

Site IT39003, Bergamo

25030

Site FR33007, Besançon

28034

Site ES34006, Madrid

Site ES34013, Madrid

28041

Site ES34015, Madrid

29609

Site FR33025, Brest

30625

Site DE49005, Hanover

Site DE49018, Hanover

31100

Site IT39021, Treviso

31403

Site FR33034, Toulouse

33076

Site FR33012, Bordeaux

33100

Site IT39001, Udine

34295

Site FR33014, Montpellier

34346

Site DE49022, Hannoversch Münden

35127

Site IT39002, Padua

35128

Site IT39010, Padua

36100

Site IT39011, Vicenza

37044

Site FR33009, Tours

Site FR33030, Tours

38320

Site ES34009, Santa Cruz de Tenerife

39008

Site ES34020, Santander

40138

Site IT39005, Bologna

Site IT39013, Bologna

40225

Site DE49013, Düsseldorf

41013

Site ES34014, Seville

41345

Site SE46001, Gothenburg

42055

Site FR33022, Saint-Etienne

44093

Site FR33023, Nantes

44892

Site DE49019, Bochum

45147

Site DE49030, Essen

46009

Site ES34021, Valencia

47011

Site ES34016, Valladolid

48903

Site ES34019, Barakaldo

49933

Site FR33020, Angers

50009

Site ES34007, Zaragoza

51014

Site EE37201, Tartu

52074

Site DE49011, Aachen

53100

Site IT39019, Siena

54511

Site FR33028, Vandœuvre-lès-Nancy

60126

Site IT39015, Ancona

60596

Site DE49001, Frankfurt am Main

63003

Site FR33027, Clermont-Ferrand

65691

Site CZ42006, Brno

67091

Site FR33017, Strasbourg

67100

Site IT39014, L’Aquila

67655

Site DE49015, Kaiserslautern

68167

Site DE49027, Mannheim

70852

Site CZ42005, Ostrava

72076

Site DE49006, Tübingen

75185

Site SE46004, Uppsala

75571

Site FR33008, Paris

75651

Site FR33010, Paris

75743

Site FR33031, Paris

75970

Site FR33019, Paris

76233

Site FR33024, Rouen

80131

Site IT39008, Naples

80211

Site PL48003, Gdansk

81377

Site DE49025, Munich

81675

Site DE49016, Munich

84131

Site IT39017, Salerno

87042

Site FR33018, Limoges

90127

Site IT39016, Palermo

92118

Site FR33003, Clichy, Paris

93042

Site DE49010, Regensburg

94000

Site FR33001, Créteil

94010

Site FR33029, Créteil

94275

Site FR33026, Le Kremlin-Bicêtre

94804

Site FR33002, Villejuif

119992

Site RU70005, Moscow

129090

Site RU70002, Moscow

Site RU70004, Moscow

129110

Site RU70007, Moscow

220116

Site BY37501, Minsk

404120

Site RU70011, Volzhskiy

Site RU70013, Volzhskiy

620102

Site RU70012, Yekaterinburg

644112

Site RU70010, Omsk

650066

Site RU70014, Kemerovo

B3H2Y9

Site CA15001, Halifax

H2X3J4

Site CA15003, Montreal

500 05

Site CZ42004, Hradec Králové

775 00

Site CZ42003, Olomouc

140 21

Site CZ42001, Prague

Site CZ42002, Prague

00029

Site FI35801, Helsinki

Site FI35802, Helsinki

06202

Site FR33004, Nice

07747

Site DE49008, Jena

00133

Site IT39004, Rome

00168

Site IT39020, Rome

LV-1002

Site LV37101, Riga

6229 HX

Site NL31001, Maastricht

40 027

Site PL48006, Katowice

91-153

Site PL48005, Lodz

60-479

Site PL48007, Poznan

70-111

Site PL48004, Szczecin

02-097

Site PL48001, Warsaw

1069-166

Site PT35102, Lisbon

975 01

Site SK42101, Banská Bystrica

833 05

Site SK42102, Bratislava

614-735

Site KR82007, Busan

700-721

Site KR82006, Daegu

05505

Site KR82002, Seoul

110-744

Site KR82005, Seoul

120-752

Site KR82001, Seoul

08907

Site ES34001, L'Hospitalet de Llobregat

Site ES34018, L'Hospitalet de Llobregat

03010

Site ES34017, Alicante

08035

Site ES34004, Barcelona

Site ES34011, Barcelona

08036

Site ES34003, Barcelona

B15 2TH

Site GB44001, Birmingham

LS7 9TF

Site GB44003, Leeds

SE5 9RS

Site GB44002, London

All Listed Sponsors
lead

Astellas Pharma Europe Ltd.

INDUSTRY

NCT02057484 - A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant | Biotech Hunter | Biotech Hunter